Amy Compton-Phillips - 31 May 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: EVP, Chief Medical Officer
Issuer ticker: CVS
Reported as of: 31 May 2025
Net transaction value: +$3,399,948
SEC form: 4
Accepted by SEC: 03 Jun 2025, 16:33:21 UTC
Prior SEC filing: 07 Nov 2025
Next SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Compton-Phillips

Key filing fact

Amy Compton-Phillips filed Form 4 for CVS HEALTH Corp (CVS) on 03 Jun 2025.

Key facts

This page summarizes Amy Compton-Phillips's Form 4 filing for CVS HEALTH Corp (CVS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2025, 16:33.

Change

Previous filing in this sequence was filed on 07 Nov 2025.
Current net transaction value: +$3,399,948.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001741492 Primary reporting owner

Compton-Phillips Amy

Relationship: EVP, Chief Medical Officer
Address: ONE CVS DRIVE, WOONSOCKET
Signature: /s/ Amy Compton-Phillips
Signature date: 03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock (RSUs)

Award

Transaction value: $2,999,954
Shares: +46,845
Change %
Price: $64.04
Shares after: 46,845
Date: 31 May 2025
Ownership: Direct
Footnotes: F1

CVS transaction

Common Stock (RSUs)

Award

Transaction value: $399,994
Shares: +6,246
Change %: +13%
Price: $64.04
Shares after: 53,091
Date: 31 May 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +27,081
Change %
Price: $0.000000
Shares after: 27,081
Date: 31 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,081
Exercise price: $64.04
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 5/31/2026.

Footnote F2

Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 5/31/2026.

Footnote F3

Option becomes exercisable in four equal annual installments, commencing 5/31/2026.